0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Discovery AI"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$4,799USDGBP
From
EUR$5,850USDGBP
From
EUR$4,490USDGBP
From
EUR$4,490USDGBP
From
EUR$5,987USDGBP
Strategic Intelligence: AI in drug discovery - Product Thumbnail Image

Strategic Intelligence: AI in drug discovery

  • Report
  • November 2024
  • 66 Pages
  • Global
From
EUR$1,950USDGBP
AI Driven Drug Discovery Patent Landscape Report - Product Thumbnail Image

AI Driven Drug Discovery Patent Landscape Report

  • Report
  • December 2024
  • 96 Pages
  • Global
From
EUR$4,713USDGBP
Drug Discovery Technologies Market Forecast to 2029 - Product Thumbnail Image

Drug Discovery Technologies Market Forecast to 2029

  • Report
  • September 2024
  • 192 Pages
  • Global
From
EUR$4,650USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Loading Indicator

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery. The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more